kongre.net
Welcome to kongre.net

Speaker

Medha Kamat

Director, Oncology Biomarker & Diagnostic Operations, Johnson & Johnson

Medha Kamat, Director, Oncology Biomarker & Diagnostic Operations at Johnson & Johnson, is speaking at Biomarker Operations & Biospecimen Management Summit (Boston, United States of America, 16–17 Nov 2026) in the session “Panel Discussion: Choosing Build vs. Buy for Sample Tracking Technology & Making Either Work at Scale”.

Conferences
1
Keynotes
0
Upcoming
1

Upcoming appearances

More speakers at Biomarker Operations & Biospecimen Management Summit

  • Lokesh Agrawal

    Chief (Acting) Biorepositories & Biospecimen Research Branch (BBRB) Cancer Diagnosis Program, National Institute of Health Science

  • Eduardo Rodriguez Almaraz

    Senior Manager, Precision Medicine & Clinical Operations Lead, Regeneron Pharmaceuticals

  • Karina Bienfait

    Executive Director & Head, Consent, Biospecimen & Imaging Management, Bristol Myers Squibb

  • Bethany Brunton

    Associate Director, Biomarker & Diagnostic Operations, Johnson & Johnson

  • Mine Cicek

    Director, Biorepositories Program, Mayo Clinic

  • Nicole Couture

    Director, Biosample Operations, Arcus Biosciences

See all 22 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Medha Kamat, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].